Merck KGaA (XTER:MRK) Effective Interest Rate on Debt % : 1.46% (As of Dec. 2023)

View and export this data going back to 1995. Start your Free Trial

What is Merck KGaA Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Merck KGaA's annualized positive value of Interest Expense for the quarter that ended in Dec. 2023 was €152 Mil. Merck KGaA's average total debt for the quarter that ended in Dec. 2023 was €10,410 Mil. Therefore, Merck KGaA's annualized Effective Interest Rate on Debt % for the quarter that ended in Dec. 2023 was 1.46%.

Merck KGaA Effective Interest Rate on Debt % Historical Data

The historical data trend for Merck KGaA's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck KGaA Effective Interest Rate on Debt % Chart

Merck KGaA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Effective Interest Rate on Debt %

Get a 7-Day Free Trial

4.32

3.08

2.39

2.22

3.17

Merck KGaA Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Effective Interest Rate on Debt %	Get a 7-Day Free Trial															0.60	2.47	5.46	3.04	1.46

Competitive Comparison of Merck KGaA's Effective Interest Rate on Debt %

For the Drug Manufacturers - Specialty & Generic subindustry, Merck KGaA's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Merck KGaA's Effective Interest Rate on Debt % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merck KGaA's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Merck KGaA's Effective Interest Rate on Debt % falls into.

Merck KGaA Effective Interest Rate on Debt % Calculation

Merck KGaA's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2023 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (A: Dec. 2022 )	+	Total Debt (A: Dec. 2023 ))	/ count )
=	-1 * -321	/	( (10398	+	9864)	/ 2 )
=	-1 * -321	/	10131
=	3.17 %

where

	Total Debt (A: Dec. 2022 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	9200	+	1198
=	10398

	Total Debt (A: Dec. 2023 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	9239	+	625
=	9864

Merck KGaA's annualized Effective Interest Rate on Debt % for the quarter that ended in Dec. 2023 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (Q: Sep. 2023 )	+	Total Debt (Q: Dec. 2023 ))	/ count )
=	-1 * -152	/	( (10956	+	9864)	/ 2 )
=	-1 * -152	/	10410
=	1.46 %

where

	Total Debt (Q: Sep. 2023 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	9540	+	1416
=	10956

	Total Debt (Q: Dec. 2023 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	9239	+	625
=	9864

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Dec. 2023) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

Merck KGaA (XTER:MRK) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.

Merck KGaA Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Merck KGaA's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.

Merck KGaA (XTER:MRK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck KGaA (XTER:MRK) » Definitions » Effective Interest Rate on Debt %

Comparable Companies

Traded in Other Exchanges

MKKGY:USA MKGAF:USA MRK:Italy MRKd:UK 0O14:UK MRCK:Austria

Address

Frankfurter Strasse 250, Darmstadt, HE, DEU, 64293

Website

https://www.emdgroup.com

Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (47% of 2022 sales) primarily provides laboratory consumables and services to researchers in academia and applied fields, including the biopharmaceutical industry. In the healthcare segment (35%), Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In its electronics segment (18%), the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.

Executives

Belén Garijo Lopez	Chair of the Executive Board
Peter Guenter	Member of the Executive Board
Dr. Matthias Heinzel	Member of the Executive Board
Dr. Marcus Kuhnert	Board of Directors